“The move comes after Shkreli, its former CEO, was charged on December 17 in federal court with securities fraud related to a hedge fund and another company. Shkreli pleaded not guilty to the charges. Shkreli initially gained notoriety in September when, as the chief executive of Turing Pharmaceuticals, he raised the price of Daraprim— a drug used to treat a dangerous parasitic infection— from $13.50 to $750 per pill. The move generated harsh criticism from prominent politicians, including Hillary Clinton, and spurred a senate investigation into drug pricing.”
http://www.nydailynews.com/news/national/martin-shkreli-company-files-bankruptcy-article-1.2481147
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Young Greeks Helping Each Other to Combat Crisis
ACLU seeks to rein in NSA mass surveillance
India finance minister to countrymen: Contain 'uncontrolled passion' for gold
NSA spied on Americans until a judge ruled it illegal in 2011
U.S. charges eight hackers over alleged cyber theft of at least $15 million
U.S. to impose 'national security' tariffs on uranium imports
Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s
British parliament budgets $150,000 to refurbish two toilets
British man who 'vanished' after being stripped of citizenship says he was tortured, forced to sign ...
Gallup Sued By DOJ After Unfavorable Obama Polls, Unemployment Numbers
Gold Deliveries From Shanghai Bourse Jump on Physical Demand
BMW takes ‘great leap forward’ into electric car market
In Legal Showdown Over Marijuana, Oakland Dispensary Takes Leading Role
Americans: 'Online Surveillance Is O.K. For Most'
Ride-sharing companies like Uber may lose ‘bandit cab’ stigma in California